Sun-Exposed vs. Non-Sun-Exposed Areas: Epidemiology and Pathogenesis of Non-Metastatic Merkel Cell Carcinoma
Authors:
- Alexander YakobsonAYAlexander Yakobson
- Ronen BrennerRBRonen Brenner
- Hanna T. Frumin EdriHEHanna T. Frumin Edri
- Anna IevkoAIAnna Ievko
- Sofiia TuraievaSTSofiia Turaieva
- Tanzilya TairovTTTanzilya Tairov
- Ilia BerezhnovIBIlia Berezhnov
- Shlomit FenigSFShlomit Fenig
- Eyal FenigEFEyal Fenig
- Tomer Ziv-BaranTZTomer Ziv-Baran
- Sabri El-SaiedSESabri El-Saied
- Walid ShalataWalid Shalata
Open Access
- 9 March 2026
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 16 (5) , 818
Abstract
Background: Merkel cell carcinoma (MCC) is a rare and aggressive cutaneous neuroendocrine malignancy. The prognostic impact of sun exposure at the primary tumor site in localized and locally advanced MCC remains incompletely defined. We aimed to compare clinicopathologic characteristics and survival outcomes between sun-exposed and non-sun-exposed MCC in a large, multi-center Israeli cohort. Methods: We retrospectively identified 249 patients diagnosed with localized or locally advanced MCC between January 1985 and December 2020. Of these, 225 patients met eligibility criteria and were included in the analysis: 142 with sun-exposed primary tumors (cohort A) and 83 with non-sun-exposed tumors (cohort B). Baseline characteristics included age, sex, tumor size, lymph node (LN) involvement at diagnosis, disease-free survival (DFS), and overall survival (OS). Results: Median age at diagnosis was similar between cohorts (~73 years), with a male predominance in both groups. LN involvement was significantly more frequent in non-sun-exposed tumors compared with sun-exposed tumors (57.0% vs. 30.0%, p < 0.001), while tumor size distribution did not differ significantly. Median DFS was numerically longer in sun-exposed patients (58.0 vs. 47.8 months, p ≈ 0.18), whereas median OS favored non-sun-exposed patients (89.7 vs. 79.7 months, p ≈ 0.21), though neither difference reached statistical significance overall. Females demonstrated longer DFS and OS than males across both cohorts. Among LN-negative patients, non-sun-exposed tumors were associated with significantly improved OS (105.9 vs. 91.4 months, p ≈ 0.03), particularly in males. Primary tumor size further stratified outcomes: non-sun-exposed patients had significantly superior OS for tumors <2 cm and both improved DFS and OS for tumors ≥2 cm. Conclusions: In this large real-world MCC cohort, sun exposure status was associated with distinct patterns of nodal involvement and survival in clinically relevant subgroups. Non-sun-exposed MCC demonstrated favorable survival outcomes, particularly in LN-negative disease and across tumor size categories, suggesting underlying biological differences that merit further investigation.Keywords
This publication has 35 references indexed in Scilit:
- Avelumab for the treatment of locally advanced or metastatic Merkel cell carcinoma—A multicenter real‐world experience in IsraelCancer Medicine, 2023
- Best practices in surgical and nonsurgical management of head and neck Merkel cell carcinoma: An updateMolecular Carcinogenesis, 2022
- Merkel Cell CarcinomaDermatologic Clinics, 2022
- Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022European Journal of Cancer, 2022
- Predictors of Nodal Metastasis in Cutaneous Head and Neck CancersCurrent Oncology Reports, 2022
- Merkel cell carcinoma in lymph nodes with and without primary originCancer Medicine, 2022
- Merkel Cell Carcinoma ReviewHematology/Oncology Clinics of North America, 2019
- Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needsEuropean Journal of Cancer, 2017
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus InfectionCell Host & Microbe, 2016
- Immunohistochemistry for Merkel cell polyomavirus is highly specific but not sensitive for the diagnosis of Merkel cell carcinoma in the Australian populationHuman Pathology, 2011